U.S. markets open in 11 minutes
  • S&P Futures

    4,413.75
    -24.25 (-0.55%)
     
  • Dow Futures

    34,482.00
    -162.00 (-0.47%)
     
  • Nasdaq Futures

    15,188.50
    -115.00 (-0.75%)
     
  • Russell 2000 Futures

    2,239.30
    -15.90 (-0.71%)
     
  • Crude Oil

    72.88
    -0.42 (-0.57%)
     
  • Gold

    1,743.60
    -6.20 (-0.35%)
     
  • Silver

    22.22
    -0.46 (-2.05%)
     
  • EUR/USD

    1.1711
    -0.0036 (-0.30%)
     
  • 10-Yr Bond

    1.4270
    +0.0170 (+1.21%)
     
  • Vix

    20.35
    -0.52 (-2.49%)
     
  • GBP/USD

    1.3675
    -0.0046 (-0.33%)
     
  • USD/JPY

    110.6430
    +0.3420 (+0.31%)
     
  • BTC-USD

    41,108.92
    -2,572.81 (-5.89%)
     
  • CMC Crypto 200

    1,022.52
    -86.40 (-7.79%)
     
  • FTSE 100

    7,051.23
    -27.12 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DEERFIELD, Ill., July 23, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced it plans to release financial results from the second quarter 2021 before the open of trading on Friday August 6, 2021.

Surgalign will host a conference call and audio webcast at 9:00 a.m. ET the same day. The conference call can be accessed by dialing (866) 604-1616 (U.S.) or (201) 689-8043 (International), using conference ID 13721429. The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for one month following the call.

About Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital surgery and is building out its digital surgery platform to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies surgeons will look to for what is truly possible for their patients. Surgalign is focused on bringing surgeons solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.

Forward Looking Statement

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.

Jonathon Singer
Investor and Media Contact
jsinger@surgalign.com
+1 877-343-6832